These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 8632608)
1. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer. Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Cho JH; Noguchi M; Ochiai A; Hirohashi S Lab Invest; 1996 Apr; 74(4):835-41. PubMed ID: 8606493 [TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Greenwald BD; Harpaz N; Yin J; Huang Y; Tong Y; Brown VL; McDaniel T; Newkirk C; Resau JH; Meltzer SJ Cancer Res; 1992 Feb; 52(3):741-5. PubMed ID: 1346256 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Huang Y; Boynton RF; Blount PL; Silverstein RJ; Yin J; Tong Y; McDaniel TK; Newkirk C; Resau JH; Sridhara R; Reid BJ; Meltzer SJ Cancer Res; 1992 Dec; 52(23):6525-30. PubMed ID: 1423299 [TBL] [Abstract][Full Text] [Related]
6. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade. Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692 [TBL] [Abstract][Full Text] [Related]
9. [The possible role of loss of heterozygosity at APC, MCC and DCC genetic loci in esophageal carcinoma]. Wang M; Lu R; Fang D Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):16-8. PubMed ID: 11776787 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer. Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615 [TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Xing EP; Yang GY; Wang LD; Shi ST; Yang CS Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761 [TBL] [Abstract][Full Text] [Related]
12. Analyses of p53 gene mutations in primary human bladder cancer. Miyamoto H; Kubota Y; Shuin T; Torigoe S; Hosaka M; Iwasaki Y; Danenberg K; Danenberg PV Oncol Res; 1993; 5(6-7):245-9. PubMed ID: 8123944 [TBL] [Abstract][Full Text] [Related]
13. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma. Brewster SF; Browne S; Brown KW J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345 [TBL] [Abstract][Full Text] [Related]
14. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers. Kannan S; Yokozaki H; Jayasree K; Sebastian P; Mathews A; Abraham EK; Nair MK; Tahara E Int J Oral Maxillofac Surg; 2002 Aug; 31(4):414-8. PubMed ID: 12361076 [TBL] [Abstract][Full Text] [Related]
15. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205 [TBL] [Abstract][Full Text] [Related]
16. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Cairns P; Proctor AJ; Knowles MA Oncogene; 1991 Dec; 6(12):2305-9. PubMed ID: 1766677 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity of tumor suppressor genes in testis cancer. Peng HQ; Bailey D; Bronson D; Goss PE; Hogg D Cancer Res; 1995 Jul; 55(13):2871-5. PubMed ID: 7796415 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations and prognosis in bladder tumors. Uchida T; Wada C; Ishida H; Wang C; Egawa S; Yokoyama E; Kameya T; Koshiba K J Urol; 1995 Apr; 153(4):1097-104. PubMed ID: 7869472 [TBL] [Abstract][Full Text] [Related]
20. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]